Skip to content

the effect of Teucrium polium on intensity of dysmenorrhea

comparison the effect of mefenamic acid and Teucrium polium on intensity of dysmenorrhea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014120917501N1
Enrollment
105
Registered
2014-12-17
Start date
2014-10-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea. Primary dysmenorrhoea

Interventions

Intervention 1: Control group: in people with inclusion criteria To be eaten placebo, contains250mg of Starch powder, oral daily (3 first day of mensturation) during 2 cycles. . pain intensity with Sy
Placebo
Treatment - Drugs
Control group: in people with inclusion criteria To be eaten placebo, contains250mg of Starch powder, oral daily (3 first day of mensturation) during 2 cycles. . pain intensity with Systemic character
Intervention group: in people with inclusion criteria To be eatenTeucrium Polium Capsule, 250mg, oral daily(3 first day of mensturation) during 2 cycles. pain intensity with Systemic characteristics a
Intervention group: in people with inclusion criteria To be eaten Mefenamic Acid Capsule, 250mg, oral daily(3 first day of mensturation) during 2 cycles. pain intensity with Systemic characteristics a

Sponsors

Shaid Beheshti University of Medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: being single; age between 20-30year old; girls with primary dysmenorrhea that the pain intensity as moderate to severe based Mac Gill ruler; do not suffering from chronic diseases (diabetes, hypertension, cardiac diseases, infectious diseases, liver, kidney); regular menstruation (period between 21 – 35 days); have not any symptoms of itching, abnormal discharge during study; they should not use any herbal remedies about 3 months ago Intervention; they should not have any deplorable event such as near relatives’ death or surgical operation in recent six months. Exclusion criteria: individual's consent to continue participating in the study; improper use of capsules; any use of herbal drug during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of primary dysmenorrhea. Timepoint: Before the intervention, while following intervention during the 3 first day of bleeding in 2cycles. Method of measurement: Verbal Multidimentional Scoring System Questionnaire, Mac gil ruler.

Secondary

MeasureTime frame
Complications. Timepoint: Finally of bleeding days. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026